isopentenyl pyrophosphate has been researched along with HIV Infections in 5 studies
isopentenyl pyrophosphate: substrate for isopentenyl pyrophosphate isomerase; RN given refers to unlabeled cpd; a nonpeptide mycobacterial antigen that stimulates gamma delta T cells
isopentenyl diphosphate : A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Excerpt | Relevance | Reference |
---|---|---|
"Peripheral blood mononuclear cells from uninfected controls and HIV+ individuals receiving anti-retroviral therapy were treated with isopentenyl pyrophosphate (IPP) or zoledronate plus IL-2 to expand the Vδ2+ subset." | 3.78 | Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity. ( Pauza, CD; Poonia, B, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murday, AS | 1 |
Chaudhry, S | 1 |
Pauza, CD | 3 |
Riedel, DJ | 1 |
Sajadi, MM | 1 |
Armstrong, CL | 1 |
Cummings, JS | 1 |
Cairo, C | 1 |
Redfield, RR | 1 |
Poonia, B | 1 |
Biswas, P | 1 |
Ferrarini, M | 1 |
Mantelli, B | 1 |
Fortis, C | 1 |
Poli, G | 1 |
Lazzarin, A | 1 |
Manfredi, AA | 1 |
Gougeon, ML | 1 |
Malkovsky, M | 1 |
Casetti, R | 1 |
Agrati, C | 1 |
Poccia, F | 1 |
1 review available for isopentenyl pyrophosphate and HIV Infections
Article | Year |
---|---|
Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
Topics: Adjuvants, Immunologic; Antigen Presentation; Antiretroviral Therapy, Highly Active; Chemokines; Dip | 2002 |
4 other studies available for isopentenyl pyrophosphate and HIV Infections
Article | Year |
---|---|
Interleukin-18 activates Vγ9Vδ2
Topics: Antigens; Cell Proliferation; Cells, Cultured; Diphosphonates; Hemiterpenes; HIV Infections; HIV-1; | 2017 |
Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD56 Antigen; Cells, Cultured; Cross-Sectional Studies | 2009 |
Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity.
Topics: Anti-Retroviral Agents; Antibody-Dependent Cell Cytotoxicity; CD56 Antigen; Cell Line, Tumor; Diphos | 2012 |
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
Topics: Apoptosis; Cell Division; Cell Line; fas Receptor; Flow Cytometry; Gene Expression Regulation, Viral | 2003 |